EDITORIAL
Overcoming preexisting alloantibody in renal transplantation—improving outcomes while reducing needs and costs

https://doi.org/10.1111/ajt.14494Get rights and content
Under a Creative Commons license
open archive

The authors discuss Axelrod et al’s cost analysis (page 3123) of incompatible kidney transplant and provide insight into treatment decisions for this population.

KEYWORDS

alloantibody
donors and donation: living
editorial/personal viewpoint
kidney transplantation/nephrology

Cited by (0)

See also: Axelrod et al.